# LYPD5

## Overview
LYPD5 is a gene located on chromosome 19q13 that encodes the protein LY6/PLAUR domain containing 5, also known as Haldisin. This protein is a member of the Ly6/uPAR family, characterized by the presence of LU domains, which typically exhibit a three-fingered folding topology. Notably, LYPD5 is a GPI-anchored protein with a unique structural feature: its N-terminal LU domain lacks a specific disulfide bond, which is generally crucial for protein stability (Leth2019Evolution). LYPD5 is identified as a biomarker of epithelial differentiation, specifically localized to the stratum granulosum of stratified squamous epithelium, suggesting a role in the terminal differentiation of keratinocytes and the formation of the skin barrier (Leth2019Evolution). While its precise biological function remains unclear, LYPD5 has been implicated in clinical contexts, such as acute myeloid leukemia, where its expression is associated with poor prognosis (Lv2018Circular; Zhou2022Functions).

## Structure
The LYPD5 protein is part of the Ly6/uPAR family, characterized by the presence of LU domains. These domains typically exhibit a three-fingered folding topology with three long loops projecting from a disulfide-rich core (Leth2019Evolution). In LYPD5, the first LU domain is notable for lacking the 2-3 disulfide bond, resulting in a domain with only three of the five typical disulfide bonds, which is a unique feature among these proteins (Leth2019Evolution). This structural variation may influence the protein's stability and function, although the specific biological role of LYPD5 remains unclear.

The LU domain's structure is generally maintained by disulfide bonds, which are crucial for the proper folding and stability of these proteins. However, the absence of certain disulfide bonds in LYPD5 suggests a potential for structural and functional diversity within the family (Leth2019Evolution). The protein is also identified as a biomarker of epithelial differentiation, specifically localized to the stratum granulosum of stratified squamous epithelium (Leth2019Evolution). While detailed atomic coordinates or 3D models for LYPD5 are not provided, the structural insights highlight the importance of disulfide bonds in its domain architecture.

## Function
LYPD5, also known as Haldisin, is a GPI-anchored protein encoded by a gene located on chromosome 19q13. It is part of the LU domain-containing protein family, which is characterized by a three-fingered folding topology with loops projecting from a disulfide-rich core. However, LYPD5 is unique in that it lacks a specific disulfide bond in its N-terminal LU domain, which is typically essential for protein stability (Leth2019Evolution).

LYPD5 is a biomarker of epithelial differentiation and is specifically confined to the stratum granulosum of the stratified squamous epithelium. Although the precise biological function of LYPD5 in healthy human cells is not fully understood, it is suggested to play a role in epithelial differentiation (Leth2019Evolution). The protein's localization to the stratum granulosum indicates its involvement in the terminal differentiation of keratinocytes, contributing to the formation of the skin barrier.

The gene encoding LYPD5 is part of a cluster of genes on chromosome 19q13, which includes other proteins with multiple LU domains. This clustering suggests an evolutionary expansion through gene duplication, potentially leading to functional diversification among these proteins (Leth2019Evolution).

## Clinical Significance
LYPD5, also known as Haldisin, is a gene encoding a GPI-anchored protein with two LU domains. Its expression and interaction patterns have been linked to various clinical outcomes, particularly in cancer. In the context of acute myeloid leukemia (AML), LYPD5 is one of the target genes associated with poor prognosis in patients exhibiting extramedullary infiltration (EMI). This suggests that alterations in LYPD5 expression may contribute to the pathogenesis of AML and its aggressive phenotypes (Lv2018Circular; Zhou2022Functions).

Although the specific biological function of LYPD5 in epithelial tissues remains unclear, its expression is confined to the stratum granulosum of the stratified squamous epithelium. High levels of related LU domain-containing proteins, such as C4.4A, have been associated with poor survival in pulmonary non-small cell adenocarcinomas, indicating a potential link between LYPD5 and cancer prognosis (Leth2019Evolution).

Despite these associations, there is limited direct evidence linking LYPD5 mutations or expression changes to specific diseases. Further research is needed to elucidate its role in disease mechanisms and its potential as a therapeutic target.


## References


[1. (Lv2018Circular) Chengfang Lv, Lili Sun, Zhibo Guo, Huibo Li, Desheng Kong, Bingqi Xu, Leilei Lin, Tianjiao Liu, Dan Guo, Jin Zhou, and Yinghua Li. Circular rna regulatory network reveals cell–cell crosstalk in acute myeloid leukemia extramedullary infiltration. Journal of Translational Medicine, December 2018. URL: http://dx.doi.org/10.1186/s12967-018-1726-x, doi:10.1186/s12967-018-1726-x. This article has 38 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-018-1726-x)

[2. (Leth2019Evolution) Julie Maja Leth, Katrine Zinck Leth-Espensen, Kristian Kølby Kristensen, Anni Kumari, Anne-Marie Lund Winther, Stephen G. Young, and Michael Ploug. Evolution and medical significance of lu domain−containing proteins. International Journal of Molecular Sciences, 20(11):2760, June 2019. URL: http://dx.doi.org/10.3390/ijms20112760, doi:10.3390/ijms20112760. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20112760)

[3. (Zhou2022Functions) Min Zhou, Xianling Gao, Xin Zheng, and Jing Luo. Functions and clinical significance of circular rnas in acute myeloid leukemia. Frontiers in Pharmacology, November 2022. URL: http://dx.doi.org/10.3389/fphar.2022.1010579, doi:10.3389/fphar.2022.1010579. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2022.1010579)